Demand is slowing down, addressable market of various businesses are shrinking, competition has intensified, business sentiments are low, world’s biggest economies are in recession and market valuations are at historic lows—seriously, the time has come to witness history’s biggest consolidation phase. We intend to re-start our blog to track the M&A and PE related events in India and in the world which will have likely impact on India. Keep visiting.
Tuesday, May 29, 2007
Ranbaxy buys 15 pc stake in Jupiter Bio
Jupiter Bioscience, a manufacturer of specialised organic compounds, today said it has alloted 14.91 per cent stake to Ranbaxy Laboratories through issue of share warrants on preferential basis for Rs 46.70 crore.
No comments:
Post a Comment